[1]
Gabr, M.T. et al. 2014. EGFR tyrosine kinase targeted compounds: in vitro antitumor activity and molecular modeling studies of new benzothiazole and pyrimido[2,1-b]benzothiazole derivatives. EXCLI Journal. 13, (May 2014), 573–585.